Cost-utility analysis of different treatments for post-traumatic stress disorder in sexually abused children

被引:19
作者
Gospodarevskaya E. [1 ]
Segal L. [2 ]
机构
[1] Liverpool School of Tropical Medicine, Clinical Research Group, Pembroke Place
[2] Division of Health Sciences, University of South Australia, Campus East, North Terrace, Adelaide, SA
基金
澳大利亚研究理事会;
关键词
Abuse Child; Selective Serotonin Reuptake Inhibitor; Childhood Sexual Abuse; Utility Estimate; Ptsd Treatment;
D O I
10.1186/1753-2000-6-15
中图分类号
学科分类号
摘要
Background: Post-traumatic stress disorder (PTSD) is diagnosed in 20% to 53% of sexually abused children and adolescents. Living with PTSD is associated with a loss of health-related quality of life. Based on the best available evidence, the NICE Guideline for PTSD in children and adolescents recommends cognitive behavioural therapy (TF-CBT) over non-directive counselling as a more efficacious treatment.Methods: A modelled economic evaluation conducted from the Australian mental health care system perspective estimates incremental costs and Quality Adjusted Life Years (QALYs) of TF-CBT, TF-CBT combined with selective serotonin reuptake inhibitor (SSRI), and non-directive counselling. The "no treatment" alternative is included as a comparator. The first part of the model consists of a decision tree corresponding to 12 month follow-up outcomes observed in clinical trials. The second part consists of a 30 year Markov model representing the slow process of recovery in non-respondents and the untreated population yielding estimates of long-term quality-adjusted survival and costs. Data from the 2007 Australian Mental Health Survey was used to populate the decision analytic model.Results: In the base-case and sensitivity analyses, incremental cost-effectiveness ratios (ICERs) for all three active treatment alternatives remained less than A$7,000 per QALY gained. The base-case results indicated that non-directive counselling is dominated by TF-CBT and TF-CBT + SSRI, and that efficiency gain can be achieved by allocating more resources toward these therapies. However, this result was sensitive to variation in the clinical effectiveness parameters with non-directive counselling dominating TF-CBT and TF-CBT + SSRI under certain assumptions. The base-case results also suggest that TF-CBT + SSRI is more cost-effective than TF-CBT.Conclusion: Even after accounting for uncertainty in parameter estimates, the results of the modelled economic evaluation demonstrated that all psychotherapy treatments for PTSD in sexually abused children have a favourable ICER relative to no treatment. The results also highlighted the loss of quality of life in children who do not receive any psychotherapy. Results of the base-case analysis suggest that TF-CBT + SSRI is more cost-effective than TF-CBT alone, however, considering the uncertainty associated with prescribing SSRIs to children and adolescents, clinicians and parents may exercise some caution in choosing this treatment alternative. © 2012 Gospodarevskaya and Segal; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 69 条
[41]  
Briggs, A., Claxton, K., Sculpher, M., (2006) Decision Modelling for Health Economic Evaluation, , Oxford: Oxford University Press
[42]  
Hatziandreu, E.J., Brown, R.E., Revicki, D.A., Turner, R., Martindale, J., Levine, S., Siegel, J.E., Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin (1994) Pharmacoeconomics, 5, pp. 249-264. , 10.2165/00019053-199405030-00008, 10146899
[43]  
Lewinsohn, P.M., Clarke, G.N., Seeley, J.R., Rohde, P., Major depression in community adolescents: age at onset, episode duration, and time to recurrence (1994) Am Acad Child Adolesc Psychiatry, 33, pp. 809-818
[44]  
Haby, M.M., Tonge, B.J., Littlefield, L., Carter, R., Vos, T., Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents (2004) Aust Nz J Psychiat, 38, pp. 579-591
[45]  
Wagner, K.D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M., Childress, A., Deas, D., Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials (2003) JAMA, 290, pp. 1033-1041. , 10.1001/jama.290.8.1033, 12941675
[46]  
Cheung, A.H., Zuckerbrot, R.A., Jensen, P.S., Ghalib, K., Laraque, D., Stein, R.E., GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management (2007) Pediatrics, 120, pp. e1313-e1326. , 10.1542/peds.2006-1395, 17974724
[47]  
Breslau, N., Davis, G.C., Peterson, E.L., Schultz, L.R., A second look at comorbidity in victims of trauma: the posttraumatic stress disorder -major depression connection (2000) Biol Psychiatry, 48, pp. 902-909. , 10.1016/S0006-3223(00)00933-1, 11074228
[48]  
Blanchard, E.B., Hickling, E.J., Malta, L.S., Jaccard, J., Devineni, T., Veazey, C.H., Galovski, T.E., Prediction of response to psychological treatment among motor vehicle accident survivors with PTSD (2003) Behav Ther, 34, pp. 351-363
[49]  
Cutajar, M., Mullen, P., Ogloff, J., Thomas, S., Wells, D., Spataro, J., Suicide and fatal overdose in child sexual abuse victims: a historical cohort study (2010) Med J Australia, 192, pp. 184-187
[50]  
Li, Z., Page, A., Martin, G., Taylor, R., Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review (2011) Soc Sci Med, 72, pp. 608-616. , 10.1016/j.socscimed.2010.11.008, 21211874